Celgene Elects Mr. Michael W. Bonney To Its Board Of Directors

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced the election of Michael W. Bonney to its Board of Directors. Mr. Bonney served as Chief Executive Officer and a member of the Board of Directors of Cubist Pharmaceuticals, Inc. from June 2003 until his retirement on December 31, 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC